Business Description
Nanjing Vazyme Biotech Co Ltd
ISIN : CNE100004ZK3
Share Class Description:
SHSE:688105: Class ACompare
Compare
Traded in other countries / regions
688105.China IPO Date
2021-11-15Description
Nanjing Vazyme Biotech Co Ltd is a biotechnology company. It is committed to research and development both in technology and products focusing on functional proteins, such as enzymes, antigens, antibodies, and polymer organic materials.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.81 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | -97.48 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 5.07 | |||||
| Beneish M-Score | -2.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9.5 | |||||
| 3-Year EBITDA Growth Rate | -58.5 | |||||
| 3-Year Book Growth Rate | 39.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.84 | |||||
| 9-Day RSI | 29.3 | |||||
| 14-Day RSI | 37.37 | |||||
| 6-1 Month Momentum % | -29.18 | |||||
| 12-1 Month Momentum % | -25.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.27 | |||||
| Quick Ratio | 2.97 | |||||
| Cash Ratio | 2.58 | |||||
| Days Inventory | 387.09 | |||||
| Days Sales Outstanding | 104.21 | |||||
| Days Payable | 170.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.44 | |||||
| Dividend Payout Ratio | 19.23 | |||||
| Forward Dividend Yield % | 5.44 | |||||
| 5-Year Yield-on-Cost % | 5.25 | |||||
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | -1.96 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.59 | |||||
| Operating Margin % | -1.34 | |||||
| Net Margin % | -1.18 | |||||
| FCF Margin % | 0.97 | |||||
| ROE % | -0.37 | |||||
| ROA % | -0.26 | |||||
| ROIC % | -0.21 | |||||
| ROC (Joel Greenblatt) % | -0.91 | |||||
| ROCE % | -0.26 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 353.85 | |||||
| PS Ratio | 7.43 | |||||
| PB Ratio | 2.3 | |||||
| Price-to-Tangible-Book | 2.44 | |||||
| Price-to-Free-Cash-Flow | 194.92 | |||||
| Price-to-Operating-Cash-Flow | 44.91 | |||||
| EV-to-EBIT | -675.4 | |||||
| EV-to-EBITDA | -675.4 | |||||
| EV-to-Revenue | 5.83 | |||||
| EV-to-FCF | 596.18 | |||||
| Price-to-Graham-Number | 6.2 | |||||
| Price-to-Net-Current-Asset-Value | 3.76 | |||||
| Price-to-Net-Cash | 5.65 | |||||
| Earnings Yield (Greenblatt) % | -0.15 | |||||
| FCF Yield % | 0.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nanjing Vazyme Biotech Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,285.365 | ||
| EPS (TTM) (Â¥) | -0.04 | ||
| Beta | 0 | ||
| Volatility % | 52.01 | ||
| 14-Day RSI | 37.37 | ||
| 14-Day ATR (Â¥) | 1.164586 | ||
| 20-Day SMA (Â¥) | 26.106 | ||
| 12-1 Month Momentum % | -25.93 | ||
| 52-Week Range (Â¥) | 17.58 - 41.49 | ||
| Shares Outstanding (Mil) | 400.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nanjing Vazyme Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nanjing Vazyme Biotech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nanjing Vazyme Biotech Co Ltd Frequently Asked Questions
What is Nanjing Vazyme Biotech Co Ltd(SHSE:688105)'s stock price today?
The current price of SHSE:688105 is ¥23.00. The 52 week high of SHSE:688105 is ¥41.49 and 52 week low is ¥17.58.
When is next earnings date of Nanjing Vazyme Biotech Co Ltd(SHSE:688105)?
The next earnings date of Nanjing Vazyme Biotech Co Ltd(SHSE:688105) is .
Does Nanjing Vazyme Biotech Co Ltd(SHSE:688105) pay dividends? If so, how much?
The Dividend Yield %  of Nanjing Vazyme Biotech Co Ltd(SHSE:688105) is 5.44% (As of Today), Highest Dividend Payout Ratio of Nanjing Vazyme Biotech Co Ltd(SHSE:688105) was 19.23. The lowest was 0.2. And the median was 0.2. The  Forward Dividend Yield % of Nanjing Vazyme Biotech Co Ltd(SHSE:688105) is 5.44%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers